Andrew Concoff, MD, FACR, CAQSM

Chief Innovation Officer at Exagen

Andrew Concoff, MD, FACR, CAQSM has extensive work experience in various roles within the medical field. Their most recent position is as the Chief Innovation Officer at Exagen Inc., where they started in October 2022. Prior to this, Dr. Concoff worked at United Rheumatology, where they held the roles of EVP, Chief Medical Officer and Executive Vice President, Chief Value Medical Officer, starting in January 2022 and September 2019, respectively. Andrew also served as a Medical Consultant at Flexion Therapeutics from November 2017 to January 2022. Dr. Concoff worked as a Physician at St. Jude Heritage Medical Group from June 2004 to September 2019 and additionally held the position of Medical Director, Musculoskeletal Rehabilitation and Wellness from January 2006 to June 2018. Before that, they served as the President of mPortent Biodata, Inc. from 2014 to December 2018.

Andrew Concoff, MD, FACR, CAQSM completed their Bachelor's Degree in Psychobiology at UCLA from 1985 to 1990. Andrew then attended The University of Texas Medical School at Houston and obtained their Doctor of Medicine (M.D.) degree from 1990 to 1994. Following this, they pursued an Internal Medicine Residency Program at UCLA from 1994 to 1997. Subsequently, Dr. Concoff completed a Rheumatology Fellowship at UCLA from 1997 to 1999 and a Sports Medicine Fellowship at UCLA from 1999 to 2001. Andrew has additional certifications including being Board Certified in Rheumatology by the American Board of Internal Medicine and holding a CAQ Sports Medicine certification from the same institution.

Links

Org chart

Timeline

  • Chief Innovation Officer

    October, 2022 - present

View in org chart